@entity1455 develops in 5-15% of @entity1 hospitalised with @entity583 . It is responsible for more than a half of all hospital deaths with survival rate of about 20%. Conventional medical therapy with use of adrenergic, vasoactive, inotropic and thrombolytic agents has failed to improve survival. Treatment strategy combine hemodynamic stabilisation with restoration of coronary blood flow. The aim of the study was evaluation of mechanical restoration of coronary blood flow in @entity1188 and to assess its influence on mortality in @entity1 with @entity583 complicated by @entity1455 . We retrospectively analysed 58 subjects: 26 @entity1 treated by primary angioplasty, 25 @entity1 with PTCA angioplasty after streptokinase treatment and 7 ones treated conservatively. TIMI 3 flow in angioplasty treated @entity1 was achieved in 70.6% with in hospital mortality rate 14%, however, when reperfusion was unsuccessful the mortality was high (80%). 12 months follow-up mortality rate was 41.8%. CONCLUSION: Successful reperfusion with coronary angioplasty of the @entity1188 can significantly reduce mortality rate in @entity1 with @entity1455 . @entity1 who survived in-hospital period have favourable one-year prognosis.

[ @entity1455 in the course of XXXX --the results of treatment during hospitalization and in long-term follow-up].

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction', 'acute myocardial infarction'] @entity1455 :: ('MESH:D012770', 'Disease') :: ['Cardiogenic shock', 'cardiogenic shock'] @entity1188 :: ('MESH:D007238', 'Disease') :: ['infarct-related artery', 'infarction related artery']
@entity583 :: (MESH:D009203,Disease) :: ['myocardial infarction']
